XML 85 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Discontinued Operations - Schedule of gain from disposal of discontinued operations (Details) - USD ($)
12 Months Ended
Dec. 27, 2023
Dec. 11, 2023
Dec. 31, 2023
Discontinued Operations      
Gain from disposal of discontinued operations     $ 1,467,451
Discontinued Operations, Disposed of by Sale | Elusys Therapeutics      
Discontinued Operations      
Upfront cash consideration $ 500,000 $ 500,000  
Percentage of gross revenue payable by the Buyer as royalty fee on an annual basis   3.00%  
Threshold aggregate amount of royalty fees that the Company should have received as of December 31, 2028   $ 5,000,000  
Less: net book value of assets and liabilities sold (1,020,549)    
Gain from disposal of discontinued operations 1,467,451    
Total liabilities assumed $ (51,400,000)